These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 26751584

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K, Neena K, Chitralekha KT, Arif AK, Tomar D, Rao DN.
    Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
    [Abstract] [Full Text] [Related]

  • 4. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T, Kraakman EM, Cornelisse YE, Haanen JB, Spits H, De Vries RR, Ottenhoff TH.
    J Immunol; 1993 May 15; 150(10):4641-51. PubMed ID: 8482851
    [Abstract] [Full Text] [Related]

  • 5. Fate of T Cells and their Secretory Proteins During the Progression of Leprosy.
    Tarique M, Saini C, Naz H, Naqvi RA, Khan FI, Sharma A.
    Curr Protein Pept Sci; 2018 May 15; 19(9):889-899. PubMed ID: 28847289
    [Abstract] [Full Text] [Related]

  • 6. Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development.
    Sampaio LH, Stefani MM, Oliveira RM, Sousa AL, Ireton GC, Reed SG, Duthie MS.
    BMC Infect Dis; 2011 Jan 26; 11():26. PubMed ID: 21269435
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Distinct Roles of Th17 and Th1 Cells in Inflammatory Responses Associated with the Presentation of Paucibacillary Leprosy and Leprosy Reactions.
    Santos MB, de Oliveira DT, Cazzaniga RA, Varjão CS, Dos Santos PL, Santos MLB, Correia CB, Faria DR, Simon MDV, Silva JS, Dutra WO, Reed SG, Duthie MS, de Almeida RP, de Jesus AR.
    Scand J Immunol; 2017 Jul 26; 86(1):40-49. PubMed ID: 28426172
    [Abstract] [Full Text] [Related]

  • 9. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery.
    Sridevi K, Khanna N, Chattree V, Pal PC, Haq W, Rao DN.
    Int Immunopharmacol; 2003 Nov 26; 3(12):1589-600. PubMed ID: 14555284
    [Abstract] [Full Text] [Related]

  • 10. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR, Chiplunkar SV, Butlin R, Samson PD, Deo MG, Gangal SG.
    Int J Lepr Other Mycobact Dis; 1993 Mar 26; 61(1):51-8. PubMed ID: 8326181
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Molecular mimicry between HSP 65 of Mycobacterium leprae and cytokeratin 10 of the host keratin; role in pathogenesis of leprosy.
    Singh I, Yadav AR, Mohanty KK, Katoch K, Bisht D, Sharma P, Sharma B, Gupta UD, Sengupta U.
    Cell Immunol; 2012 Mar 26; 278(1-2):63-75. PubMed ID: 23121977
    [Abstract] [Full Text] [Related]

  • 13. In vitro effect of interleukin-2 on proliferative responses of peripheral blood T cells from leprosy patients.
    Choi IH, Shin JS, Kim JD, Kim SJ.
    Yonsei Med J; 1991 Sep 26; 32(3):237-42. PubMed ID: 1781183
    [Abstract] [Full Text] [Related]

  • 14. Emerging Concepts of Adaptive Immunity in Leprosy.
    Sadhu S, Mitra DK.
    Front Immunol; 2018 Sep 26; 9():604. PubMed ID: 29686668
    [Abstract] [Full Text] [Related]

  • 15. Increase in TGF-β secreting CD4⁺CD25⁺ FOXP3⁺ T regulatory cells in anergic lepromatous leprosy patients.
    Saini C, Ramesh V, Nath I.
    PLoS Negl Trop Dis; 2014 Sep 26; 8(1):e2639. PubMed ID: 24454972
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2.
    Mohagheghpour N, Gelber RH, Larrick JW, Sasaki DT, Brennan PJ, Engleman EG.
    J Immunol; 1985 Aug 26; 135(2):1443-9. PubMed ID: 2989366
    [Abstract] [Full Text] [Related]

  • 18. Production of transforming growth factor-beta 1 (TGF-beta1) by blood monocytes from patients with different clinical forms of leprosy.
    Goulart IM, Mineo JR, Foss NT.
    Clin Exp Immunol; 2000 Dec 26; 122(3):330-4. PubMed ID: 11122237
    [Abstract] [Full Text] [Related]

  • 19. Serum Th1/Th2 and macrophage lineage cytokines in leprosy; correlation with circulating CD4(+) CD25(high) FoxP3(+) T-regs cells.
    Abdallah M, Attia EA, Saad AA, El-Khateeb EA, Lotfi RA, Abdallah M, El-Shennawy D.
    Exp Dermatol; 2014 Oct 26; 23(10):742-7. PubMed ID: 25109693
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.